Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56<sup>bright</sup>CD16<sup>−</sup> subset

Irene Veneziani(Bambino Gesù Children's Hospital), Enrico Maggi(Bambino Gesù Children's Hospital)
Journal for ImmunoTherapy of Cancer
January 1, 2022
Cited by 43


Related Papers